Central Toxic Keratopathy after Surface Laser Refractive Surgery: a Case Series and Brief Review
Journal of Ophthalmic and Optometric Sciences,
Vol. 2 No. 3 (2018),
23 June 2018
,
Page 24-30
https://doi.org/10.22037/joos.v2i3.29572
Abstract
Purpose: To describe clinical presentation, management, and outcomes of central toxic keratopathy developing after surface laser refractive surgeries.
Patients and Methods: In this retrospective case series, the records of 10 eyes of 5 patients (1 male, 4 female) were reviewed. The laser refractive surgery consisted of photorefractive surgery (PRK; 2eyes) and laser-assisted subepithelial keratectomy (LASEK; 8 eyes). Mitomycin C,
0.02 % was applied intraoperatively in all eyes.
Results: The mean patient age was 30 ± 14.5 years, (22 to 56 years). Presenting symptom was decreased vision without pain or photophobia in all cases that began 3 to 9 days postoperatively. The slit-lamp examination revealed corneal opacities and corneal thinning in the central area of the cornea corresponding to the ablated zone. There were no corneal epithelial defects or corneal stromal infiltration. Upon presentation, the mean best-corrected distance visual acuity was 20/25 (LogMAR 0.83 ± 0.34). The opacification persisted for a minimum of two months to a maximum of 6 months before clearing. The patients were followed up for 12 months. Five eyes had a decrease of 1 to 2 lines in preoperative best-corrected distance visual acuity 6 months postoperatively. All eyes had hyperopic shift and astigmatism during the follow-up period. The mean spherical equivalent at final follow up was + 0.75 ± 1.15 D.
Conclusion: Central toxic keratopathy is a non-inflammatory central corneal opacification which is associated with significant hyperopic shift and stromal tissue loss. Visual prognosis is usually good but a decrease in best-corrected distance visual acuity may persist in some cases.
Keywords: Central Toxic Keratopathy; Refractive surgical procedures; Review
How to Cite
References
Hazin R, Daoud YJ, Khalifa YM. What is Central Toxic Keratopathy Syndrome if it is not Diffuse lamellar Keratitis Grade IV?. Middle East Afr J Ophthalmol. 2010;17(1):60-2.
Fraenkel GE, Cohen PR, Sutton GL, Lawless MA, Rogers CM. Central focal interface opacity after laser in situ keratomileusis. J Refract Surg. 1998;14(5):571-6.
Sonmez B, Maloney RK. Central toxic keratopathy: description of a syndrome in laser refractive surgery. Am J Ophthalmol. 2007;143(3):420-7.
Parolini B, Marcon G, Panozzo GA. Central necrotic lamellar inflammation after laser in situ keratomileusis. J Refract Surg. 2001;17(2):110-2.
Linebarger EJ, Hardten DR, Lindstrom RL. Diffuse lamellar keratitis: diagnosis and management. J Cataract Refract Surg. 2000;26(7):1072-7.
Hadden OB, McGhee CN, Morris AT, Gray TB, Ring CP, Watson AS. Outbreak of diffuse lamellar keratitis caused by marking-pen toxicity. J Cataract Refract Surg. 2008;34(7):1121-4.
Rosman M, Chua WH, Tseng PS, Wee TL, Chan WK. Diffuse lamellar keratitis after laser in situ keratomileusis associated with surgical markerpens. J Cataract Refract Surg. 2008;34(6):974-9.
Gil-Cazorla R, Teus MA, de Benito-Llopis L, Fuentes I. Incidence of diffuse lamellar keratitis after laser in situ keratomileusis associated with the IntraLase 15 kHz femtosecond laser and Moria M2 microkeratome. J Cataract Refract Surg. 2008;34(1):28-31.
Neira W, Holopainen JM, Tervo TM. Long-term outcome of central toxic keratopathy after photorefractive keratectomy. Cornea. 2011;30(11):1207-12.
Trattler WB1, Barnes SD. Current trends in advanced surface ablation. Curr Opin Ophthalmol. 2008;19(4):330-4.
Sikder S, Khalifa YM, Neuffer MC, Moshirfar M. Tomographic corneal profile analysis of central toxic keratopathy after LASIK. Cornea. 2012;31(1):48-51.
Thornton IL, Foulks GN, Eiferman RA. Confocal microscopy of central toxic keratopathy. Cornea. 2012;31(8):934-6.
Lipshitz I, Loewenstein A, Varssano D, Lazar M. Late onset corneal haze after photorefractive keratectomy for moderate and high myopia. Ophthalmology. 1997;104(3):369-73; discussion 373-4.
Moller-Pedersen T, Cavanagh HD, Petroll WM, Jester JV. Stromal wound healing explains refractive instability and haze development afterphotorefractive keratectomy: a 1-year confocal microscopic study. Ophthalmology. 2000;107(7):1235-45.
Teal P, Breslin C, Arshinoff S, Edmison D. Corneal subepithelial infiltrates following excimer laser photorefractive keratectomy. J Cataract Refract Surg. 1995;21(5):516-8.
Gartry DS, Muir MG, Lohmann CP, Marshall J. The effect of topical corticosteroids on refractive outcome and corneal haze after photorefractive keratectomy. A prospective, randomized, double-blind trial. Arch Ophthalmol. 1992;110(7):944-52.
O'Brart DP, Lohmann CP, Klonos G, Corbett MC, Pollock WS, Kerr-Muir MG, Marshall J. The effects of topical corticosteroids and plasmin inhibitors on refractive outcome, haze, and visual performance after photorefractive keratectomy. A prospective, randomized, observer-masked study. Ophthalmology. 1994;101(9):1565-74.
- Abstract Viewed: 185 times
- PDF Downloaded: 325 times
